Verily is a Healthcare Foundation Models company founded in 2015 and based in Dallas, United States. It has raised $3.8B in total funding, most recently a Growth in 2026.
| Date | Stage | Amount | Valuation | Lead investors |
|---|---|---|---|---|
| Mar 19, 2026 | Growth | $300M | — | Series X Capital |
| Sep 9, 2022 | Growth | $1B | — | Alphabet |
| Dec 17, 2020 |
| Growth |
| $700M |
| — |
| Alphabet, Silver Lake, Temasek Holdings, Ontario Teachers' Pension Plan |
| Jan 3, 2019 | Growth | $1B | — | Silver Lake |
| Jan 26, 2017 | Growth | $800M | — | Temasek Holdings |
No articles ingested yet for Verily. Once the hourly news pipeline is live, every article the classifier tags as mentioning this company appears here with its one-line AI summary and sentiment.
Verily Pre is an AI-native platform purpose-built for precision health. It enables researchers and innovators to harmonize, exchange, govern, and analyze biomedical data, and to build and deploy AI models and agents directly into care and research workflows. Pre includes Verily Intelligence, a set of AI features that support data extraction, curation, and analysis using FHIR model standards. It targets health systems, life science companies, and payers who need to streamline data management and train next-generation AI models for healthcare.
Lightpath is a personalized virtual care program by Verily that combines clinical expertise, patient health data, and AI-powered support to help members manage chronic conditions. It pairs members with a dedicated care team and provides personalized educational resources, connected device integration (e.g., CGMs for diabetes), and always-on support. Lightpath aims to make chronic disease management more proactive and accessible by delivering tailored, data-driven care directly to individuals through a mobile app.
Verily Viewpoint is a solution suite designed to accelerate clinical research. It includes AI-driven tools for digitizing clinical trial protocols, managing study operations, and generating real-world evidence. Viewpoint helps researchers streamline site operations, reduce trial timelines, and gain faster insights from complex biomedical data. It is built on the Pre platform and leverages Verily's data harmonization capabilities to connect fragmented healthcare data, making clinical research more efficient and scalable.
Verily Sightline provides solutions to monitor and mitigate population-level disease. It enables health organizations to detect, track, and respond to disease trends across populations using advanced analytics and AI. Sightline leverages the Pre platform's data harmonization capabilities to aggregate and analyze diverse data sources, giving public health officials and health systems a clearer view of disease spread and risk factors to enable earlier interventions and resource allocation.
We don't have a live feed for this company's ATS. Their careers page has every open role.
View all careers ↗